GLG LLC’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$3.01M Hold
18,426
0.22% 121
2017
Q3
$3.78M Sell
18,426
-1,713
-9% -$398K 0.25% 111
2017
Q2
$4.9M Sell
20,139
-2,341
-10% -$550K 0.3% 96
2017
Q1
$5.37M Sell
22,480
-51
-0.2% -$11.9K 0.3% 93
2016
Q4
$4.73M Sell
22,531
-23,945
-52% -$4.96M 0.33% 81
2016
Q3
$10.7M Buy
46,476
+6,958
+18% +$1.7M 0.76% 30
2016
Q2
$9.13M Buy
39,518
+9,471
+32% +$2.18M 0.69% 32
2016
Q1
$8.05M Sell
30,047
-8,125
-21% -$2.33M 0.5% 58
2015
Q4
$11.9M Sell
38,172
-118,852
-76% -$35.4M 0.71% 32
2015
Q3
$42.7M Buy
157,024
+15,022
+11% +$4.61M 1.07% 20
2015
Q2
$43.1M Buy
142,002
+21,173
+18% +$6.32M 0.92% 24
2015
Q1
$36M Sell
120,829
-18,609
-13% -$5.31M 1.02% 16
2014
Q4
$35.9M Buy
139,438
+4,500
+3% +$1.12M 1.08% 8
2014
Q3
$32.6M Buy
134,938
+88,201
+189% +$19.7M 0.87% 13
2014
Q2
$10.4M Buy
46,737
+5,000
+12% +$1.04M 0.31% 91
2014
Q1
$8.59M Buy
+41,737
New +$8.27M 0.29% 97

Other funds holding AGN

GLG LLC's AGN Position: Q4 2017 in Review

GLG LLC held its Allergan plc (AGN) position steady in Q4 2017 at 18,426 shares worth $3.01M. The position accounts for 0.22% of the portfolio, ranked #121.

GLG LLC first reported a position in AGN in Q1 2014 and has held it in 16 quarters since. The position peaked at $43.1M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • GLG LLC held 18,426 shares of Allergan plc worth $3.01M as of Q4 2017.
  • GLG LLC left its Allergan plc share count unchanged in Q4 2017.
  • Allergan plc made up 0.22% of GLG LLC's portfolio in Q4 2017, its #121 holding.
  • GLG LLC first reported a position in Allergan plc in Q1 2014 and has held it in 16 quarters since.
  • GLG LLC's Allergan plc position peaked at $43.1M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.